OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Publication Date
Release Date
2022
(7)
2025
(6)
2021
(6)
2024
(5)
2023
(3)
2016
(2)
2015
(2)
2014
(2)
2013
(2)
2020
(1)
2012
(1)
2011
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Effects of Blended (Yellow) vs Forced Coagulation (Blue) Currents on Adverse Events, Complete Resection, or Polyp Recurrence After Polypectomy in a Large Randomized Trial.
Not available
S-EPMC8262363
|
biostudies-literature
Cite
Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Not available
S-EPMC10356620
|
biostudies-literature
Cite
International Survey of Medical Students Exposure to Relevant Global Surgery (ISOMERS): A Cross-Sectional Study.
Not available
S-EPMC9174132
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Global hospital-based disease management of acute diverticulitis: a prospective, international cohort study.
Not available
S-EPMC12512976
|
biostudies-literature
Cite
The African Critical Illness Outcomes Study (ACIOS): a point prevalence study of critical illness in 22 nations in Africa.
Not available
S-EPMC11872788
|
biostudies-literature
Cite
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4549177
|
biostudies-literature
Cite
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3536921
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets